Health
Covid-19 Variant Vaccine From Moderna Begins Human Testing – The Wall Street Journal
Testing will evaluate whether a new shot from the biotech will better target a strain first identified in South Africa
Moderna Inc.
MRNA -3.52%
said Wednesday that the first study volunteers have received modified Covid-19 vaccines designed to better target a more contagious variant of the coronavirus, marking a milestone in the race to stay ahead of the shifting pathogen.The Cambridge, Mass., company, which has one of the Covid-19 vaccines widely in use, plans to enroll 60 people to test the new shot.The subjects had previously received the standard two doses of Modernas original shot as part of a mid-stage study…
-
Noosa News11 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business16 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business15 hours agoWhere will Nvidia stock be in 1 year?
-
General15 hours agoAboriginal policy vacuum from Liberals, Labor as NAIDOC Week starts